The effectiveness of oral Tranexamic Acid on prevention of rebleeding in patients with acute upper gastrointestinal bleeding

Comparison of the effectiveness of oral Tranexamic Acid in control of gastrointestinal bleeding in patients with acute upper gastrointestinal bleeding

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190116042380N1

Enrollment

375

Registered

2019-03-04

Start date

2019-01-06

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Upper Gastrointestinal Bleeding.

Interventions

Intervention 1: Control group: participants in this group was given four 250 mg placebo capsule (Corn Starch) daily, for 3 days. Intervention 2: Intervention group 1: participants in this group was gi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients With Acute Upper Gastrointestinal Bleeding

Exclusion criteria

Exclusion criteria: Patient's discontent Clean base Ulcers in Endoscopy Malignant Ulcers in Endoscopy

Design outcomes

Primary

Measure	Time frame
Gastrointestinal Bleeding. Timepoint: one, Two and Three Days After Drug Consumption. Method of measurement: Hemoglubin Drop, Gastrointestinal Rebleeding.	—

Secondary

Measure	Time frame
Hemoglobin Drop. Timepoint: Gastrointestinal Rebleeding. Method of measurement: Serial Hemoglobin measurement.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Akbar Shayesteh

Ahvaz University of Medical Sciences

habibi.n@ajums.ac.ir+98 61 3292 1839

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026